Pharmasset

Antios raises a further $75M to fuel pursuit of hepatitis B cure

Antios is going full throttle in pursuit of a curative hepatitis B therapy, raising $75 million just months after its previous round to fund phase 2b.

Nick Paul Taylor Nov 3, 2021 9:15am

Barclays loses patience with Gilead, tells it to change up its strategy

Mar 10, 2017 4:16am